Allergic diseases are dominated by systemic type 2 inflammation with overexpression of cytokines such as IL-4 and IL-13, which, in the skin, regulate the epidermal barrier and the effector phase of the immune response (7, 8). This evidence concerns the gene IL4 and allergic disease.